NEW STEP BY STEP MAP FOR GILTERITINIB

Indicated as monotherapy for Older people with HR-optimistic, HER2-unfavorable Sophisticated or metastatic breast most cancers with illness development subsequent endocrine therapy and prior chemotherapy in metastatic location 200 mg PO BIDThis section collects any details citations, facts availability statements, or supplementary resources include